On August 18, 2020 Emergent BioSolutions Inc. (NYSE: EBS) reported that members of the company’s executive management team will participate in the following virtual investor conferences through the end of September 2020 (Press release, Emergent BioSolutions, AUG 18, 2020, View Source [SID1234569794]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2020 NYSE Healthcare & Technology Investor Access Day
August 18 – virtual one-on-one meetings only

2020 Three Part Advisors Virtual Midwest IDEAS Investor Conference
August 27 – pre-recorded presentation available beginning at 8:00am eastern

2020 Wells Fargo Virtual Healthcare Conference
September 9 – presentation at 8:00am eastern

Robert W. Baird 2020 Global Healthcare Conference
September 10 – presentation at 2:35pm eastern

Morgan Stanley 18th Annual Global Healthcare Conference 2020
September 14 – presentation at 4:30pm eastern

Cantor Virtual Global Healthcare Conference 2020
September 15 – presentation at 3:20pm eastern

2020 Singular Research Compelling Values Webcall
September 17 – presentation at 12:00pm eastern
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website www.emergentbiosolutions.com under "Investors."